Cargando…
Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
BACKGROUND: Impressive survival outcome of our previous study in unresectable hepatocellular carcinoma (HCC) patients undergoing yttrium-90 glass microspheres transarterial radioembolization (TARE) with/without sorafenib according to individuals’ disease burden, i.e., intrahepatic tumor load (IHT) a...
Autores principales: | Teyateeti, Ajalaya, Mahvash, Armeen, Long, James, Abdelsalam, Mohamed, Avritscher, Rony, Kaseb, Ahmed, Odisio, Bruno, Ravizzini, Gregory, Surasi, Devaki, Teyateeti, Achiraya, Macapinlac, Homer, Kappadath, Srinivas Cheenu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704272/ https://www.ncbi.nlm.nih.gov/pubmed/35068861 http://dx.doi.org/10.3748/wjg.v27.i47.8166 |
Ejemplares similares
-
Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020) -
Temporary Reversal of Hepatoenteric Collaterals during (90)Y Radioembolization Planning and Administration
por: Habibollahi, Peiman, et al.
Publicado: (2022) -
Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency
por: Smith, Justin, et al.
Publicado: (2013) -
Blood flow diversion using the microvascular plug to avoid non target delivery of radioactive microspheres
por: Abdelsalam, Mohamed E., et al.
Publicado: (2020) -
Minimally invasive image-guided therapies for hepatocellular carcinoma
por: Abdelsalam, Mohamed E, et al.
Publicado: (2016)